Polymorphic 4-hydroxylation of Debrisoquine in Chronic Discoid Psoriasis
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Danhof M, Breimer D
. Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers. Br J Clin Pharmacol. 1979; 8(6):529-37.
PMC: 1429894.
DOI: 10.1111/j.1365-2125.1979.tb01040.x.
View
2.
Chapman P, Keys B, Rawlins M, Moss C, Shuster S
. Antipyrine clearance in psoriasis. Br Med J (Clin Res Ed). 1981; 282(6257):20-1.
PMC: 1503795.
DOI: 10.1136/bmj.282.6257.20.
View
3.
Shuster S, Rawlins M, Chapman P, Rogers S
. Decreased epidermal aryl hydrocarbon hydroxylase and localized pustular psoriasis. Br J Dermatol. 1980; 103(1):23-6.
DOI: 10.1111/j.1365-2133.1980.tb15833.x.
View
4.
Chapman P, Rawlins M, Shuster S
. Activity of aryl hydrocarbon hydroxylase in psoriatic skin. Lancet. 1979; 1(8111):297-8.
DOI: 10.1016/s0140-6736(79)90706-2.
View
5.
Chapman P, Rawlins M, Shuster S
. The activity of aryl hydrocarbon hydroxylase in adult human skin. Br J Clin Pharmacol. 1979; 7(5):499-503.
PMC: 1429572.
DOI: 10.1111/j.1365-2125.1979.tb00993.x.
View